1. |
高润霖. 急性心肌梗死诊断和治疗指南.中华心血管病杂志, 2001, 29(12): 711.
|
2. |
Nicolas Danchin, Edoardo De Benedetti, Phil ip Urban. Treatment of acute myocardial infarction. Clinical Evidence, 2003, (9):23-4. 葛宁, 译. 中国循证医学杂志, 2004, 4(6): 426.
|
3. |
Zeymer U,Neuhaus KL.Thrombolys is and percutaneous transluminal coronary angioplasty in patients with acute myocardial infarction. Z Kardiol, 2000, 89 Suppl 4: IV30-40.
|
4. |
Sodi-Pallares D, Testell i MR, Fischelder BL,et al. Effects of an intravenous infusion of potassium-glucose-insul in solution on the electrocardiographic signs of myocardial infarction. Am J Cardiol, 1962, 9: 166–181.
|
5. |
Bucciarell i-Ducci C, Bianchi M, De Luca L, et al. Effects of glucose-insulin-potassium infusion on myocardial perfusion and left ventricular remodel ing in patients treated with primary angioplasty for ST-elevation acute myocardial infarction. Am J Cardiol, 2006, 98(10): 1349-1353.
|
6. |
Krljanac G, Vasiljevic Z, Radovanovic M, et al. Effects of glucose-insulin-potassium infusion on ST-elevation myocardial infarction in patients treated with thrombolytic therapy. Am J Cardiol, 2005, 96(8): 1053-1058.
|
7. |
Van der Horst IC, De Luca G, Ottervanger JP, et al. ST-segment elevation resolution and outcome in patients treated with primary angioplasty and glucose-insulin-potassium infusion. Am Heart J, 2005, 149(6): 1135.
|
8. |
Van der Horst IC, Ottervanger JP, van ‘t Hof AW, et al. The impact of glucose-insul in-potassium infusion in acute myocardial infarction on infarct size and left ventricular ejection fraction. BMC Med, 2005, 3: 9.
|
9. |
Castro PF, Larrain G, Baeza R,et al. Effects of glucose-insulin-potassium solution on myocardial salvage and left ventricular function after primary angioplasty. Crit Care Med, 2003, 31(8): 2152-2155.
|
10. |
Zhu P, Lu L, Xu Y,et al. Glucose-insulin-potassium preserves systolic and diastolic function in ischemia and reperfusion in pigs. Am J Physiol Heart Circ Physiol, 2000, 278: H595-603.
|
11. |
Jonassen AK, Aasum E, Riemersma RA,et al. Glucose-insulin-potassium reduces infarct size when administered during reperfusion. Cardiovasc Drugs Ther, 2000, 14: 615-623.
|
12. |
Addo TA, Keeley EC, Cigarroa JE, et al. Effect of glucose-insulin-potassium infusion on plasma free fatty acid concentrations in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction. Am J Cardiol, 2004, 94(10): 1288-1289.
|
13. |
Opie LH, Tansey M, Kennelly BM. Proposed metabolic vicious circle in patients with large myocardial infaRCT and high plasma-free-fatty-acid concentrations. Lancet, 1977, 2: 890–892.
|
14. |
Oliver MF, Kurien VA, Greenwood TW. Relation between serum-free-fatty acids and arrhythmias and death after acute myocardial infarction. Lancet, 1968, 1: 710 –714.
|
15. |
Mehta SR, Yusuf S, Diaz R,et al. CREATE-ECLA Trial Group Investigators. Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction:the CREATE-ECLA randomized controlled trial. JAMA, 2005, 293(4): 437-446.
|
16. |
Diaz R, Paolasso EA, Piegas LS,et al. Metabol ic modulation of acute myocardial infarction. The ECLA(Estudios Cardiologicos Latinoamerica) Collaborative Group.Circulation,1998,98: 2227-2234.
|
17. |
Van der Horst IC, Zijlstra F, van’t Hof AW, et al. Glucose-insulin-potassium infusion in patients treated with primary angioplasty for acute myocardial infarction:the Glucose-Insulin-Potassium Study: a randomized trial. J Am Coll Cardiol, 2003, 42: 784 -791.
|
18. |
Malmberg K, Ryden L, Efendic S, et al. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. J Am Coll Cardiol, 1995, 26: 57- 65.
|
19. |
Carl S. Apstein1 and Lionel H. Opie. A challenge to the metabolic approach to myocardial ischaemia. Eur Heart J, 2005, 26(10): 956-959.
|